For irreversible monoamine oxidase inhibitors (MAOIs), see MAOI. Reversible inhibitors of monoamine oxidase A (RIMAs) are a class of drugs which selectively and reversibly inhibit the enzyme monoamine oxidase A (MAO-A). They are used clinically in the treatment of depression and dysthymia, though they have not gained widespread market share due to limited efficacy relative to other antidepressants. Because of their reversibility and selectivity, RIMAs are safer than the older monoamine oxidase inhibitors (MAOIs).[1]
Source: PsychonautWiki — RIMA ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.